Effect of extracts from iris milk-white and celery on body composition and glucose levels in leptin-resistant mice

Introduction. The practical approach to treating diabetes mellitus often overlooks the management of obesity, focusing primarily on glycemic control. Consequently, there is a growing need to explore pharmacological strategies for obesity treatment within the so-called diabetic syndrome. Certain plant species contain a wide range of biologically active compounds that may have beneficial effects on metabolic processes in the body.

Aim. To investigate the effects of a complex of polyphenolic compounds from Iris lactea herb and polysaccharides and pectins from Apium graveolens rhizomes on body weight and fat content in leptin-resistant diabetic mice.

Materials and methods. The experiment employed bioimpedance analysis and blood biochemical analysis to measure glucose levels.

Results and discussion. It was found that the studied phytosubstances led to a reduction in body weight and adipose tissue proportion in the animals compared to the control group. Additionally, the group treated with Iris lactea extracts showed a decrease in blood glucose levels.

Conclusion. The obtained data confirm the potential use of Iris lactea and Apium graveolens extracts as sources of bioactive compounds for developing obesity treatment agents.

1. Michaelidou M., Pappachan J. M., Jeeyavudeen M. S. Management of diabesity: Current concepts. World Journal of Diabetes. 2023;14(4):396–411. DOI: 10.4239/wjd.v14.i4.396.

2. Kumar S., Mittal A., D. Babu, Mittal A. Herbal Medicines for Diabetes Management and its Secondary Complications. Current Diabetes Reviews. 2021;17(4):437–456. DOI: 10.2174/1573399816666201103143225.

3. Okovityi S. V., Bolotova V. Ts., Anisimova N. A., Ivkin D. Yu., Titovich I. A., Sysoev Yu. I., Napalkova S. M. Prospects for using plant extracts to correct fat and carbohydrate metabolism disorders. Pharmacy. 2020;69(2):17–22. (In Russ.) DOI: 10/29296/25419218-2020-02-03.

4. Luzhanin V. G., Whaley A. K., Ponkratova A. O., Zhokhova E. V., Zingalyuk M. A., Pryaknina N. I. Iris milky-white (Iris lactea Pall.) – a promising source of biologically active substances. Chemistry of plant raw material. 2021;3:5–17. (In Russ.) DOI: 10.14258/jcprm.2021038890.

5. Bychkova N. V., Kalashnikova A. A., Wylie A. K., Luzhanin V. G., Kalinina N. M., Shustov E. B., Okovity S. V. Study of the immunotropic effects of the flavone glycoside embinin. Preventive and Clinical Medicine. 2019;4(73):77–82. (In Russ.)

6. Ivkin D. Yu., Luzhanin V. G., Karpov A. A., Minasyan S. M., Poleshchenko Ya. I., Mamedov A. E., Povydysh M. N., Poroykov V. V., Narkevich I. A. Embinin is a perspective cardiotonic mean for natural origin. Drug development & registration. 2018;(3):166–170. (In Russ.)

7. Barkas F., Bathrellou E.; Nomikos T., Panagiotakos D., Liberopoulos E., Kontogianni M. D. Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention. Nutrients. 2023;15(3):2845. DOI: 10.3390/nu15132845.

8. Amiri S., Dastghaib S., Ahmadi M., Mehrbod P., Khadem F., Behrouj H., Aghanoori M.-R., Machaj F., Ghamsari M., Rosik J., Hudecki A., Afkhami A., Hashemi M., Los M. J., Mokarram P., Madrakian T., Ghavami S. Betulin and its derivatives as novel compounds with different pharmacological effects. Biotechnology Advances. 2020;38:107409. DOI: 10.1016/j.biotechadv.2019.06.008.

9. Mehraj N., Alam M. Karafs (Apium graveolens Linn) An indepth review of its historical context, therapeutic properties, ethno pharmacological applications, and scientific research. Journal of Pharmacognosy and Phytochemistry. 2024;13(3):401–405. DOI: 10.22271/phyto.2024.v13.i3e.14981.

10. Yan Y., Li Q., Shen L., Guo K., Zhou X. Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice. Frontiers in Endocrinology. 2022;13:1042044. DOI: 10.3389/fendo.2022.1042044.

11. Nani A., Murtaza B., Sayed Khan A., Khan N. A., Hichami A. Antioxidant and Anti-Inflammatory Potential of Polyphenols Contained in Mediterranean Diet in Obesity: Molecular Mechanisms. Molecules. 2021;26(4):985. DOI: 10.3390/molecules26040985.

12. Ahmad E., Sargeant J., Zaccardi F., Khunti K., Webb D., Davies M. Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes? Pharmaceuticals. 2020;13(12):427. DOI: 10.3390/ph13120427.

13. Lazzaroni E., Ben Nasr M., Loretelli C., Pastore I., Plebani L., Lunati M. E., Vallone L., Bolla A. M., Rossi A., Montefusco L., Ippolito E., Berra C., D’Addio F., Zuccotti G. V., Fiorina P. Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharmacological Research. 2021;171:105782. DOI: 10.1016/j.phrs.2021.105782.

14. Liu J., Lai F., Hou Y., Zheng R. Leptin signaling and leptin resistance. Medical Review. 2022;2(4):363–384. DOI: 10.1515/mr-2022-0017.

15. Kottaisamy C. P. D., Raj D. S., Prasanth Kumar V., Sankaran U. Experimental animal models for diabetes and its related complications—a review. Laboratory Animal Research. 2021;37:23. DOI: 10.1186/s42826-021-00101-4.

16. Demakova N. V., Krasnova M. V., Plisko G. A., Semivelichenko E. D., Ivkin D. Yu., Okovityy S. V. Impedansometry as an estimating method of tertiary endpoint in experimental modeling of alimentary impairments. Laboratory Animals for Science. 2021;2:54–60. (In Russ.)

17. Surbeeva E. S., Komova S. I. Extraction and purification of polysaccharide fractions from Apium graveolens L. roots. In: XI International Scientific and Practical Conference "Young Pharmacy – Potential of the Future". St. Petersburg; 2022. (In Russ.)